2012
DOI: 10.1007/s10620-012-2450-7
|View full text |Cite
|
Sign up to set email alerts
|

Thrombocytopenia in Patients with Chronic Liver Disease: What’s in a Name?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 17 publications
1
5
0
Order By: Relevance
“…In agreement with a previously published study [32] , which confirmed that decreased platelet count was a good indicator of the severity of chronic liver diseases, we found that serum albumin levels were significantly lower (P = 0.026) and INR values were significantly higher (P <0.001) in thrombocytopenic than non-thrombocytopenic patients. Furthermore, platelet count showed significant positive correlation with serum albumin levels (r = 0.579; P < 0.001) and negative correlation with INR values (r = -0.694; P < 0.001).…”
Section: Discussionsupporting
confidence: 93%
“…In agreement with a previously published study [32] , which confirmed that decreased platelet count was a good indicator of the severity of chronic liver diseases, we found that serum albumin levels were significantly lower (P = 0.026) and INR values were significantly higher (P <0.001) in thrombocytopenic than non-thrombocytopenic patients. Furthermore, platelet count showed significant positive correlation with serum albumin levels (r = 0.579; P < 0.001) and negative correlation with INR values (r = -0.694; P < 0.001).…”
Section: Discussionsupporting
confidence: 93%
“…Through a meta-analysis, Zhang et al showed that thrombocytopenia in HCC patients was associated with poor OS (HR: 1.47, 95% CI 1.21–1.78) and poor RFS (HR: 1.41, 95% CI: 1.22–1.62) in HCC patients after hepatic resection [35]. Platelet count has been used to assess the severity of chronic liver disease and features of portal hypertension [36]. In the present study, low SII was associated with high APRI and high INR, which are related to significant fibrosis and poor liver function.…”
Section: Discussionmentioning
confidence: 99%
“…This evidence is supported by the lack of correlation between HVPG value and platelet count, and by the absence of influence of β‐blockers administration on indirect indexes of portal hypertension . Thus, thrombocytopaenia, which may be influenced by various factors not necessarily linked with portal hypertension, should be considered a poor surrogate marker for HVPG in these patients . Indeed, the study which assessed both HVPG and indirect indexes of portal hypertension in 40 patients who underwent HR for HCC showed that criteria used to indirectly assess clinically significant portal hypertension overestimate the proportion of patients who actually had portal hypertension: in fact, while 26 individuals were classified as portal hypertensive cases using indirect criteria, only 18 showed an HVPG ≥10 mmHg .…”
Section: Discussionmentioning
confidence: 99%